162 related articles for article (PubMed ID: 9206694)
1. [Interferon-alpha in chronic myeloid leukemia].
Hehlmann R
Fortschr Med; 1997 Mar; 115(9):30-4, 37-8. PubMed ID: 9206694
[TBL] [Abstract][Full Text] [Related]
2. [Chronic myeloid leukemia].
Hehlmann R
Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
[TBL] [Abstract][Full Text] [Related]
3. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress in therapy for chronic myelogenous leukemia].
Urabe A
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
[TBL] [Abstract][Full Text] [Related]
5. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
[TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha in the treatment of chronic myelogenous leukemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313
[TBL] [Abstract][Full Text] [Related]
8. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
Urabe A
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
[TBL] [Abstract][Full Text] [Related]
9. Approaches to the treatment of chronic myeloid leukemia.
Savage DG; Goldman JM
Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
[TBL] [Abstract][Full Text] [Related]
10. Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemia.
Meloni G; Capria S; Vignetti M; Alimena G; de Fabritiis P; Montefusco E; Mandelli F
Haematologica; 2001 Jun; 86(6):596-601. PubMed ID: 11418368
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
12. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
Tomás JF; López-Lorenzo JL; Requena MJ; Aguilar R; Steegmann JL; Cámara R; Alegre A; Arranz R; Figuera A; Fernández-Rañada JM
Bone Marrow Transplant; 1998 Jul; 22(1):47-51. PubMed ID: 9678795
[TBL] [Abstract][Full Text] [Related]
13. Use of interferon in the treatment of chronic myelogenous leukemia.
Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):3-7. PubMed ID: 7992097
[TBL] [Abstract][Full Text] [Related]
14. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
15. Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation.
J Clin Oncol; 1999 Jun; 17(6):1858-68. PubMed ID: 10561226
[TBL] [Abstract][Full Text] [Related]
16. [Developments in the treatment of patients with chronic myeloid leukemia].
Cornelissen JJ; Löwenberg B
Ned Tijdschr Geneeskd; 1997 Oct; 141(40):1904-9. PubMed ID: 9550736
[TBL] [Abstract][Full Text] [Related]
17. New perspectives with interferon alpha. The German CML study group experience.
Hehlmann R; Ansari H; Adelberger V; Heinze B; Hossfeld K; Hochhaus A; Heimpel H
Bone Marrow Transplant; 1994; 14 Suppl 3():S14-20. PubMed ID: 7697004
[No Abstract] [Full Text] [Related]
18. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
19. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
Sacha T; Hawrylecka D; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():62-6. PubMed ID: 10494185
[TBL] [Abstract][Full Text] [Related]
20. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
Griesshammer M; Heimpel H
Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
[No Abstract] [Full Text] [Related]
[Next] [New Search]